Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Assets (2016 - 2025)

Historic Assets for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $598.1 million.

  • Lemaitre Vascular's Assets rose 5862.85% to $598.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $598.1 million, marking a year-over-year increase of 5862.85%. This contributed to the annual value of $551.8 million for FY2024, which is 5912.69% up from last year.
  • Per Lemaitre Vascular's latest filing, its Assets stood at $598.1 million for Q3 2025, which was up 5862.85% from $577.6 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Assets high stood at $598.1 million for Q3 2025, and its period low was $246.5 million during Q2 2021.
  • Its 5-year average for Assets is $367.4 million, with a median of $326.5 million in 2023.
  • As far as peak fluctuations go, Lemaitre Vascular's Assets tumbled by 360.24% in 2021, and later surged by 5912.69% in 2024.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Assets stood at $292.8 million in 2021, then rose by 6.04% to $310.5 million in 2022, then rose by 11.69% to $346.8 million in 2023, then surged by 59.13% to $551.8 million in 2024, then rose by 8.38% to $598.1 million in 2025.
  • Its Assets stands at $598.1 million for Q3 2025, versus $577.6 million for Q2 2025 and $556.0 million for Q1 2025.